Specialty Pharmacy

Mechanism behind novel BRAF inhibitor resistance among patients with melanoma discovered.

Top news of the day from across the health care landscape.

Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers carry similar outcomes in study.

Aromatase inhibitors in human estrogen-receptor positive breast cancer can cause tumor mutations.

A 4-dimensional lung scanning platform may advance patient care.

Patients taking medication that inhibits IL-1beta are 300 times more likely to develop a flesh-eating infection.

Research identifies which melanoma patients will respond to immunotherapy drugs.

The lack of rigid fatigue descriptions in multiple sclerosis inhibit treatment advances.

Obesity becoming a growing health concern for cancer survivors, specifically breast and colorectal cancers.

Brain training exercise may help treat patients with conditions such as dementia.

Protein inhibition shows promising reducing lung cancer progression.

Researchers seek to develop drugs that block the Nef protein that is associated with HIV progressing to AIDS.

Patient satisfaction and coordination of care are vital to the success of a high cost specialty drug regimen.

Study will be the first to evaluate the role of metformin on liver fibrosis in HCV-HIV co-infected and HCV mono-infected patients.

Drug resistance not found to increase among patients with HIV.

Sedentary behavior can lead to cardiovascular disease, and in turn, diabetic retinopathy.

Direct acting antiviral drugs may increase adverse events after liver transplantation.

MicroRNA clusters may influence immune cell generation.

Caucasians found to have better skin cancer survival rates.

Top news of the day from across the health care landscape.

Top news of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology, and cancer drug development.

Researchers explore harnessing power of immune system to kill HIV.

The confidence of pharmacists dispensing biosimilars along with varying opinions on naming conventions influence uptake of interchangeable biologic drugs.

Wide range of prescription drugs drive lowest fertility levels in more than a century.

Top news of the day from across the health care landscape.

Work advances on drug for hepatitis B the rare disease alpha-1 antitrypsin deficiency.

Discovery may help tumor suppression on a molecular level.